Financial statements Consolidated statements of cash flows 2017 2016 2015 Years ended December 31 $M $M $M Cash flow from operating activities: Net income 4,271.5 327.4 1,303.4 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 2,264.2 1,466.3 637.2 Share-based compensation 174.9 318.5 100.3 Amortization of deferred financing fees 12.8 125.5 Expense related to the unwind of inventory fair value adjustments 747.8 1,118.0 31.1 Change in deferred taxes 2,916.4 594.6 198.2 Change in fair value of contingent consideration 120.7 11.1 149.9 Impairment of PP&E and intangible assets 289.9 101.3 643.7 Other, net 55.6 31.4 Changes in operating assets and liabilities: Increase in accounts receivable 487.6 701.7 211.4 Increase in sales deduction accrual 314.1 288.3 97.6 Increase in inventory 145.1 255.8 63.2 Decrease increase in prepayments and other assets 81.1 198.4 37.2 Decrease increase in accounts payable and other liabilities 526.8 621.6 109.2 Net cash provided by operating activities 4,256.7 2,658.9 2,337.0 Cash flow from investing activities: Purchases of PP&E 798.8 648.7 114.7 Purchases of businesses, net of cash acquired 17,476.2 5,553.4 Proceeds from sale of investments 88.6 0.9 85.7 Movements in restricted cash 13.7 62.8 32.0 Other, net 23.0 31.0 5.5 Net cash used in investing activities 700.9 18,092.2 5,619.9 The accompanying notes are an integral part of these consolidated financial statements.
126 Shire Annual Report 2017 2017 2016 2015 Years ended December 31 $M $M $M Cash flow from financing activities: Proceeds from revolving line of credit, long term and short term borrowings 4,236.7 32,443.4 3,760.8 Repayment of revolving line of credit, long term and short term borrowings 7,681.4 16,404.3 3,110.9 Payment of dividend 281.3 171.3 134.4 Debt issuance costs 172.3 24.1 Proceeds from issuance of stock for share-based compensation arrangements 134.1 169.2 16.6 Other, net 27.4 38.9 69.0 Net cash used in provided by financing activities 3,619.3 15,825.8 439.0 Effect of foreign exchange rate changes on cash and cash equivalents 7.1 0.8 3.0 Net decrease increase in cash and cash equivalents 56.4 393.3 2,846.9 Cash and cash equivalents at beginning of period 528.8 135.5 2,982.4 Cash and cash equivalents at end of period 472.4 528.8 135.5 Supplemental information: Interest paid 554.2 284.0 20.0 Income taxes paid, net 524.7 431.0 69.0 For stock issued as purchase consideration for the acquisition of Baxalta related to non-cash investing activities, refer to Note 4, Business Combinations, to these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
Shire Annual Report 2017 127 Other information Financial statements Governance Strategic report
